Literature DB >> 26770292

A modified classification tree method for personalized medicine decisions.

Wan-Min Tsai1, Heping Zhang2, Eugenia Buta3, Stephanie O'Malley4, Ralitza Gueorguieva5.   

Abstract

The tree-based methodology has been widely applied to identify predictors of health outcomes in medical studies. However, the classical tree-based approaches do not pay particular attention to treatment assignment and thus do not consider prediction in the context of treatment received. In recent years, attention has been shifting from average treatment effects to identifying moderators of treatment response, and tree-based approaches to identify subgroups of subjects with enhanced treatment responses are emerging. In this study, we extend and present modifications to one of these approaches (Zhang et al., 2010 [29]) to efficiently identify subgroups of subjects who respond more favorably to one treatment than another based on their baseline characteristics. We extend the algorithm by incorporating an automatic pruning step and propose a measure for assessment of the predictive performance of the constructed tree. We evaluate the proposed method through a simulation study and illustrate the approach using a data set from a clinical trial of treatments for alcohol dependence. This simple and efficient statistical tool can be used for developing algorithms for clinical decision making and personalized treatment for patients based on their characteristics.

Entities:  

Keywords:  Binary tree; Classification tree; Decision tree; Personalized medicine; Recursive partitioning; Subgroup; Tailored treatment

Year:  2016        PMID: 26770292      PMCID: PMC4707681          DOI: 10.4310/SII.2016.v9.n2.a11

Source DB:  PubMed          Journal:  Stat Interface        ISSN: 1938-7989            Impact factor:   0.582


  19 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

Authors:  Ralitza Gueorguieva; Ran Wu; Dennis Donovan; Bruce J Rounsaville; David Couper; John H Krystal; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-12-08       Impact factor: 3.455

3.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

4.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

5.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

6.  A regression tree approach to identifying subgroups with differential treatment effects.

Authors:  Wei-Yin Loh; Xu He; Michael Man
Journal:  Stat Med       Date:  2015-02-05       Impact factor: 2.373

7.  Effects of alcoholism typology on response to naltrexone in the COMBINE study.

Authors:  Michael P Bogenschutz; J Scott Tonigan; Helen M Pettinati
Journal:  Alcohol Clin Exp Res       Date:  2008-09-30       Impact factor: 3.455

8.  Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

Authors:  Barbara J Mason; Anita M Goodman; Sylvie Chabac; Philippe Lehert
Journal:  J Psychiatr Res       Date:  2006-03-20       Impact factor: 4.791

9.  Combining biomarkers to optimize patient treatment recommendations.

Authors:  Chaeryon Kang; Holly Janes; Ying Huang
Journal:  Biometrics       Date:  2014-05-30       Impact factor: 2.571

10.  An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Authors:  Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David Couper; Robert Swift; Helen Pettinati; David Goldman
Journal:  Arch Gen Psychiatry       Date:  2008-02
View more
  3 in total

Review 1.  Artificial intelligence and machine learning in precision and genomic medicine.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-06-15       Impact factor: 3.738

2.  Predictors and moderators of treatment efficacy in reducing custodial grandmothers' psychological distress.

Authors:  Gregory C Smith; Gregory R Hancock; Bert Hayslip
Journal:  Aging Ment Health       Date:  2021-01-04       Impact factor: 3.658

3.  Artificial intelligence with multi-functional machine learning platform development for better healthcare and precision medicine.

Authors:  Zeeshan Ahmed; Khalid Mohamed; Saman Zeeshan; XinQi Dong
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.